Neuropsychiatric Disease and Treatment
Volume 19, 2023 - Issue
COMMENTARY
Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations
Allan H Young1 Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UKCorrespondence[email protected]
https://orcid.org/0000-0003-2291-6952View further author information
https://orcid.org/0000-0003-2291-6952View further author information, Mohamed Abdelghani2 Camden and Islington NHS Foundation Trust, London, UKhttps://orcid.org/0000-0002-9888-6588View further author information
https://orcid.org/0000-0002-9888-6588View further author information, , & Ramin Nilforooshan4 Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, UK;5 Faculty of Health and Medical Sciences, University of Surrey, Guildford, UKhttps://orcid.org/0000-0001-9801-183XView further author information
https://orcid.org/0000-0001-9801-183XView further author information